diabetes mellitus, type 2
Showing NaN - NaN of 73
Diabetes, Type 2, Peripheral Arterial Disease Trial in Worldwide (Semaglutide, Placebo (semaglutide))
Recruiting
- Diabetes Mellitus, Type 2
- Peripheral Arterial Disease
- Semaglutide
- Placebo (semaglutide)
-
Birmingham, Alabama
- +179 more
Jan 23, 2023
Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, sitagliptin, )
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- semaglutide
- +2 more
-
Anniston, Alabama
- +241 more
Jul 11, 2022
Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, )
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- semaglutide
- placebo
-
Little Rock, Arkansas
- +228 more
Jul 11, 2022
Diabetes, Type 2 Trial in Worldwide (Semaglutide, Placebo (semaglutide))
Active, not recruiting
- Diabetes Mellitus, Type 2
- Semaglutide
- Placebo (semaglutide)
-
Montgomery, Alabama
- +444 more
Mar 11, 2022
Diabetes, Diabetes, Type 2 Trial in Worldwide (Faster-acting insulin aspart, Insulin aspart, Insulin degludec)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- Faster-acting insulin aspart
- +3 more
-
Concord, California
- +166 more
Jan 6, 2022
Ischemic Heart Disease Chronic, Diabetes, Type 2 Trial in Germany (lifestyle intervention, usual care)
Completed
- Ischemic Heart Disease Chronic
- Diabetes Mellitus, Type 2
- lifestyle intervention
- usual care
-
Aachen, Germany
- +9 more
Nov 4, 2021
Diabetes, Type 2, Coronary Artery Disease Trial in Worldwide (Apabetalone, Placebo, Atorvastatin)
Completed
- Diabetes Mellitus, Type 2
- Coronary Artery Disease
- Apabetalone
- +3 more
-
Bahía Blanca, Argentina
- +213 more
Jul 23, 2021
Hyperlipidemia, Diabetes, Type 2, Non-Insulin Dependent Diabetes Trial in Germany (Atorvastatin, Placebo)
Terminated
- Hyperlipidemia
- +2 more
- Atorvastatin
- Placebo
-
BAD Muenster AM Stein, Germany
- +13 more
Feb 17, 2021
Diabetes, Type 2 Trial in Worldwide (Albiglutide, Insulin Glargine and Insulin Lispro)
Completed
- Diabetes Mellitus, Type 2
- Albiglutide
- Insulin Glargine and Insulin Lispro
-
Searcy, Arkansas
- +157 more
Nov 13, 2020
Diabetes, Type 2 Trial in Worldwide (Ticagrelor 60 mg, Ticagrelor )
Completed
- Diabetes Mellitus, Type 2
- Ticagrelor 60 mg
- Ticagrelor placebo
-
Alexander City, Alabama
- +1241 more
Mar 4, 2020
Diabetes, Type 2 Trial in Worldwide (linagliptin, glimepiride, linagliptin )
Diabetes, Type 2, Diabetic Nephropathy Trial in Worldwide (Canagliflozin, Placebo)
Completed
- Diabetes Mellitus, Type 2
- Diabetic Nephropathy
- Canagliflozin
- Placebo
-
Birmingham, Alabama
- +592 more
Dec 4, 2019
Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, Dulaglutide)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
-
Tuscumbia, Alabama
- +208 more
Oct 2, 2019
Diabetes, Diabetes, Type 2 Trial in Worldwide (Semaglutide, Liraglutide)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
-
Burgas, Bulgaria
- +91 more
Oct 2, 2019
Cardiovascular Disease, Diabetes, Type 2 Trial in Worldwide (Dulaglutide, Placebo)
Completed
- Cardiovascular Disease
- Diabetes Mellitus, Type 2
- Dulaglutide
- Placebo
-
Mobile, Alabama
- +300 more
Sep 18, 2019
Diabetes, Type 2 Trial in Worldwide (Human Insulin Inhalation Powder, Insulin Glargine)
Completed
- Diabetes Mellitus, Type 2
- Human Insulin Inhalation Powder
- Insulin Glargine
-
Fresno, California
- +68 more
Sep 6, 2019
Diabetes, Type 2 Trial in Worldwide (Human Insulin Inhalation Powder, Injectable insulin)
Completed
- Diabetes Mellitus, Type 2
- Human Insulin Inhalation Powder
- Injectable insulin
-
Sacramento, California
- +42 more
Sep 6, 2019
Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, )
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- liraglutide
- placebo
-
Alabaster, Alabama
- +427 more
Jul 3, 2019
Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, exenatide)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
-
Anniston, Alabama
- +145 more
May 28, 2019
Diabetes, Type 2 Trial in Worldwide (Placebo, Linagliptin)
Diabetes, Type 2, Albuminuria Trial in Worldwide (Placebo, Canagliflozin, 100 mg, Canagliflozin, 300 mg)
Completed
- Diabetes Mellitus, Type 2
- Albuminuria
- Placebo
- +2 more
-
Little Rock, Arkansas
- +353 more
Nov 19, 2018
Diabetes, Type 2, Cardiovascular Diseases, Risk Factors Trial in Worldwide (Placebo, Canagliflozin (JNJ-28431754) 100 mg,
Completed
- Diabetes Mellitus, Type 2
- +2 more
- Placebo
- +2 more
-
Birmingham, Alabama
- +312 more
Nov 5, 2018